DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Neurostimulation Devices Market Analysis By Product, By Application And Segment Forecasts To 2024" report to their offering.
The neurostimulation devices market is expected to reach USD 9.8 billion by 2024. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024.
This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent device approval regulations are expected to hamper the growth.
Apart from the above mentioned factors, increasing incidence of road traffic accidents (RTAs) is also an additional factor propagating growth. Hence, the neurostimulation devices market holds enormous growth prospects and as a result manufacturers are participating in precise R&D exercises to develop new products empowered by advance technology. Some of the technological advancements such as the following are expected to serve as drivers:
Companies Mentioned:
- Medtronic
- St. Jude Medical
- Boston Scientific Corporation
- Cyberonics
- Nevro Corporation
- Neuronetics, Inc.
- Uroplasty, Inc.
- Codman & Shurtleff, Inc.
- IntraPace, Inc.
Report Structure:
1 Research Methodology
2 Executive Summary
3 Market Variables, Trends & Scope
4 Market Categorization 1: Product Estimates & Trend Analysis
5 Market Categorization 2: Application Estimates & Trend Analysis
6 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application
7 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/4zvb4z/neurostimulation